281 related articles for article (PubMed ID: 31608504)
1. The use of curcumin as an effective adjuvant to cancer therapy: A short review.
Bashang H; Tamma S
Biotechnol Appl Biochem; 2020 Mar; 67(2):171-179. PubMed ID: 31608504
[TBL] [Abstract][Full Text] [Related]
2. Identification of a novel compound (β-sesquiphellandrene) from turmeric (Curcuma longa) with anticancer potential: comparison with curcumin.
Tyagi AK; Prasad S; Yuan W; Li S; Aggarwal BB
Invest New Drugs; 2015 Dec; 33(6):1175-86. PubMed ID: 26521943
[TBL] [Abstract][Full Text] [Related]
3. Curcumin: a promising agent targeting cancer stem cells.
Zang S; Liu T; Shi J; Qiao L
Anticancer Agents Med Chem; 2014; 14(6):787-92. PubMed ID: 24851881
[TBL] [Abstract][Full Text] [Related]
4. Curcumin in combined cancer therapy.
Troselj KG; Kujundzic RN
Curr Pharm Des; 2014; 20(42):6682-96. PubMed ID: 25341940
[TBL] [Abstract][Full Text] [Related]
5. Terpecurcumins A-I from the rhizomes of Curcuma longa: absolute configuration and cytotoxic activity.
Lin X; Ji S; Li R; Dong Y; Qiao X; Hu H; Yang W; Guo D; Tu P; Ye M
J Nat Prod; 2012 Dec; 75(12):2121-31. PubMed ID: 23153397
[TBL] [Abstract][Full Text] [Related]
6. Recent advances of analogues of curcumin for treatment of cancer.
Zhao S; Pi C; Ye Y; Zhao L; Wei Y
Eur J Med Chem; 2019 Oct; 180():524-535. PubMed ID: 31336310
[TBL] [Abstract][Full Text] [Related]
7. Multiple biological activities of curcumin: a short review.
Maheshwari RK; Singh AK; Gaddipati J; Srimal RC
Life Sci; 2006 Mar; 78(18):2081-7. PubMed ID: 16413584
[TBL] [Abstract][Full Text] [Related]
8. Multifocal signal modulation therapy of cancer: ancient weapon, modern targets.
Das T; Sa G; Saha B; Das K
Mol Cell Biochem; 2010 Mar; 336(1-2):85-95. PubMed ID: 19826768
[TBL] [Abstract][Full Text] [Related]
9. Curcumin: the Indian solid gold.
Aggarwal BB; Sundaram C; Malani N; Ichikawa H
Adv Exp Med Biol; 2007; 595():1-75. PubMed ID: 17569205
[TBL] [Abstract][Full Text] [Related]
10. Bioactive chemical constituents of Curcuma longa L. rhizomes extract inhibit the growth of human hepatoma cell line (HepG2).
Abdel-Lateef E; Mahmoud F; Hammam O; El-Ahwany E; El-Wakil E; Kandil S; Abu Taleb H; El-Sayed M; Hassenein H
Acta Pharm; 2016 Sep; 66(3):387-98. PubMed ID: 27383887
[TBL] [Abstract][Full Text] [Related]
11. Cell growth regulation.
Karunagaran D; Joseph J; Kumar TR
Adv Exp Med Biol; 2007; 595():245-68. PubMed ID: 17569215
[TBL] [Abstract][Full Text] [Related]
12. Anti-Cancer Activity of Curcumin on Multiple Myeloma.
Mirzaei H; Bagheri H; Ghasemi F; Khoi JM; Pourhanifeh MH; Heyden YV; Mortezapour E; Nikdasti A; Jeandet P; Khan H; Sahebkar A
Anticancer Agents Med Chem; 2021; 21(5):575-586. PubMed ID: 32951583
[TBL] [Abstract][Full Text] [Related]
13. Molecular targets for the management of cancer using Curcuma longa Linn. phytoconstituents: A Review.
Sultana S; Munir N; Mahmood Z; Riaz M; Akram M; Rebezov M; Kuderinova N; Moldabayeva Z; Shariati MA; Rauf A; Rengasamy KRR
Biomed Pharmacother; 2021 Mar; 135():111078. PubMed ID: 33433356
[TBL] [Abstract][Full Text] [Related]
14. Combined therapy using bevacizumab and turmeric ethanolic extract (with absorbable curcumin) exhibited beneficial efficacy in colon cancer mice.
Yue GG; Kwok HF; Lee JK; Jiang L; Wong EC; Gao S; Wong HL; Li L; Chan KM; Leung PC; Fung KP; Zuo Z; Lau CB
Pharmacol Res; 2016 Sep; 111():43-57. PubMed ID: 27241019
[TBL] [Abstract][Full Text] [Related]
15. Active Compounds from
Lesmana R; Susianti ; Pediatama T; Sylviana N; Susanti Pratiwi Y; Goenawan H; Supratman U
Pak J Biol Sci; 2021 Jan; 24(1):35-41. PubMed ID: 33683029
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacological researches of curcumin solid dispersions in treatment of cancer].
Mei XT; Xu DH; He XN; Lu YC
Zhong Yao Cai; 2012 Oct; 35(10):1645-9. PubMed ID: 23627135
[TBL] [Abstract][Full Text] [Related]
17. Multitargeting by turmeric, the golden spice: From kitchen to clinic.
Gupta SC; Sung B; Kim JH; Prasad S; Li S; Aggarwal BB
Mol Nutr Food Res; 2013 Sep; 57(9):1510-28. PubMed ID: 22887802
[TBL] [Abstract][Full Text] [Related]
18. Curcumin's Beneficial Effects on Neuroblastoma: Mechanisms, Challenges, and Potential Solutions.
Zhai K; Brockmüller A; Kubatka P; Shakibaei M; Büsselberg D
Biomolecules; 2020 Oct; 10(11):. PubMed ID: 33105719
[TBL] [Abstract][Full Text] [Related]
19. Curcumin as tyrosine kinase inhibitor in cancer treatment.
Golonko A; Lewandowska H; Świsłocka R; Jasińska UT; Priebe W; Lewandowski W
Eur J Med Chem; 2019 Nov; 181():111512. PubMed ID: 31404861
[TBL] [Abstract][Full Text] [Related]
20. Curcumin and its formulations: potential anti-cancer agents.
Ji JL; Huang XF; Zhu HL
Anticancer Agents Med Chem; 2012 Mar; 12(3):210-8. PubMed ID: 22044005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
